Literature DB >> 15380563

The chance of cure following surgery for drug-resistant temporal lobe epilepsy. What do we know and do we need to revise our expectations?

Dieter Schmidt1, Christoph Baumgartner, Wolfgang Löscher.   

Abstract

Although surgery is often seen as a curative treatment for patients with drug-resistant temporal lobe epilepsy, little information is available how many cases can be considered cured after surgery, i.e. are seizure-free for several years without taking antiepileptic drugs (AEDs). In our review, 13 retrospective and five prospective clinical observations published since 1980 provided data on long-term seizure control off AEDs in a total of 1658 patients. No randomized studies were found. Following temporal lobe surgery, approximately one in four adult patients and approximately one in three children or adolescents can currently shown to be seizure-free for 5 years without AEDs (25%, mean of eight studies in adults, 95% CI: 21-30%, and 31%, mean of three studies in children, 95% CI: 20-41%). The rate of seizure control off AEDs seemed to be stable after 2 years of follow-up. However, as 55% of patients free of disabling seizures preferred not to discontinue their medication completely as late as 5 years after surgery, it is impossible to know if they are cured or not. No features predictive of surgical cure were detected except for better cure outcome in children versus adults with hippocampal sclerosis and in patients with typical versus atypical Ammonshorn's sclerosis or tumor in one small study each. In conclusion, the available evidence on seizure outcome off AEDs after temporal lobe surgery is based on non-randomized studies and, in part, data were collected retrospectively. A randomized controlled trial is needed to determine if, in fact only one in three to four patients with temporal lobe epilepsy undergoing surgery can be considered cured.

Entities:  

Mesh:

Year:  2004        PMID: 15380563     DOI: 10.1016/j.eplepsyres.2004.07.004

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  6 in total

1.  Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections?

Authors:  Barbara Schmeiser; Bernhard J Steinhoff; Andreas Schulze-Bonhage
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

Review 2.  Pharmacoresistance and the role of surgery in difficult to treat epilepsy.

Authors:  Samuel Wiebe; Nathalie Jette
Journal:  Nat Rev Neurol       Date:  2012-09-11       Impact factor: 42.937

3.  Individual Brain Metabolic Connectome Indicator Based on Jensen-Shannon Divergence Similarity Estimation Predicts Seizure Outcomes of Temporal Lobe Epilepsy.

Authors:  Zehua Zhu; Zhimin Zhang; Xin Gao; Li Feng; Dengming Chen; Zhiquan Yang; Shuo Hu
Journal:  Front Cell Dev Biol       Date:  2022-01-11

Review 4.  Identification of common predictors of surgical outcomes for epilepsy surgery.

Authors:  Jing Zhang; Weifang Liu; Hui Chen; Hong Xia; Zhen Zhou; Shanshan Mei; Qingzhu Liu; Yunlin Li
Journal:  Neuropsychiatr Dis Treat       Date:  2013-11-06       Impact factor: 2.570

5.  Long-term therapeutic effects of corticoamygdalohippocampectomy for bilateral mesial temporal lobe epilepsy.

Authors:  Zhang Guangming; Zhou Wenjing; Lin Jiuluan; Sun Zhaohui; Zhang Bingqing; Sun Gaoxiang; Zuo Huancong
Journal:  Surg Neurol Int       Date:  2013-11-14

Review 6.  The right and the wrong with epilepsy and her science.

Authors:  Simon Shorvon; Dieter Schmidt
Journal:  Epilepsia Open       Date:  2016-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.